Otal flare designer 5-user group license 1-year term march 30, 2021 to march 29, 2022
Ended Purchase Order Awarded
- Contract number
- 75N95C21P00057
- Awardee
-
Cresset Biomolecular Discovery LIMITED UEI YFVNHK9FS147
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,575
Award facts
- Contract value 100% obligated
- $15,575.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Great Britain, United Kingdom
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N95C21P00057?
75N95C21P00057 was awarded to Cresset Biomolecular Discovery LIMITED by National Center for Advancing Translational Sciences (National Institutes of Health) on March 15, 2021.
How much is contract 75N95C21P00057 worth?
The government has obligated $15,575 on 75N95C21P00057.
Was contract 75N95C21P00057 competed?
The extent of competition for 75N95C21P00057 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award